Shandong Weigao boosts treasury holdings with latest share repurchase

Shandong Weigao Group Medical Polymer Company Limited (HKEX:1066) completed a share repurchase on September 9, 2025, acquiring 1,140,000 H shares through the Exchange. The repurchased shares were held as treasury shares. The average repurchase price was HK$5.7204 per share, with prices ranging from HK$5.7 to HK$5.75, totaling HK$6,521,200.

This transaction decreased issued shares (excluding treasury shares) from 4,507,519,924 to 4,506,379,924. Consequently, treasury shares increased from 14,812,400 to 15,952,400. The repurchase represents 0.0253% of the existing number of issued shares (excluding treasury shares) before the event. The company holds a mandate to repurchase 451,560,392 shares, of which 9,304,000 shares have been repurchased to date.

The share repurchase was conducted under a mandate granted on May 27, 2025, representing 2.0604% of the issued shares (excluding treasury shares) at that time. A moratorium period for new share issues or treasury share sales is in effect until October 9, 2025.